Literature DB >> 2877651

Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus.

M Laakso, K Pyörälä, H Sarlund, E Voutilainen.   

Abstract

We measured serum lipid and lipoprotein levels in 63 insulin-dependent diabetic (IDD) patients (32 men, 31 women) and in 63 nondiabetic control subjects (32 men, 31 women) without coronary heart disease (CHD) and in 19 IDD patients (11 men, 8 women) and in 18 nondiabetic subjects (8 men, 10 women) with CHD. All diabetic patients had postglucagon C-peptide levels of less than 0.60 mmol/liter and none had signs of renal failure. Male IDD patients with CHD had higher levels of total cholesterol, low density lipoprotein (LDL) cholesterol, total triglycerides, very low density lipoprotein (VLDL) triglycerides and lower level of high density lipoprotein (HDL) cholesterol than male IDD patients without CHD. In female IDD patients, similar lipid and lipoprotein abnormalities were observed between the groups of diabetics with and without CHD except for total cholesterol, which was the same in both groups. A comparison between IDD patients without CHD and nondiabetic control subjects without CHD showed no difference in lipid and lipoprotein levels in males; female IDD patients without CHD showed even higher levels of HDL and HDL2 cholesterol and lower levels of VLDL triglycerides than nondiabetic controls. Our results indicate that in IDD patients without nephropathy and CHD, the lipid and lipoprotein levels do not differ from nondiabetic controls, but in IDD patients with CHD the lipid and lipoprotein pattern is similar to that known to be characteristic for nondiabetic patients with CHD.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877651     DOI: 10.1161/01.atv.6.6.679

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  7 in total

Review 1.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

2.  Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.

Authors:  C M Barbagallo; M R Averna; S Amato; G Marino; M Labisi; A C Rao; M Barbagallo; G F Cupidi; A Notarbartolo
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

3.  Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study.

Authors:  U J Schauer; D Pissarek; G Panzram
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

4.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

5.  Lipoprotein pattern in long-term diabetes of an at least 35 years' duration. Results of the Erfurt Study.

Authors:  U J Schauer; G Panzram; D Pissarek; K Rühling; L Winkler; R Lundershausen
Journal:  Klin Wochenschr       Date:  1988-08-01

6.  Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  S S Soedamah-Muthu; Y-F Chang; J Otvos; R W Evans; T J Orchard
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

7.  Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M R Taskinen; J Kahri; V Koivisto; J Shepherd; C J Packard
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.